Related Experiment Video
Updated: Jun 6, 2026

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Machine learning-driven investigation on liquid-liquid phase separation-related prognostic signature in diffuse large
Zhen-Zhong Zhou1,2, Jia-Chen Lu1,2, Zhao Wang1,2
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
British Journal of Haematology
|June 5, 2026
Summary
A new prognostic model using liquid-liquid phase separation-related genes (LRGs) effectively stratifies diffuse large B-cell lymphoma (DLBCL) patients. This 6-LRG model improves risk prediction and identifies distinct biological characteristics for better patient outcomes.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma, exhibiting significant heterogeneity.
- Current risk stratification methods for DLBCL may not fully capture the disease's complexity.
Purpose of the Study:
- To develop and validate a prognostic model based on liquid-liquid phase separation-related genes (LRGs) for improved DLBCL risk stratification.
- To explore the biological and microenvironmental differences between risk groups identified by the model.
Main Methods:
- Analysis of transcriptomic and clinical data from four independent cohorts (n=768).
- Application of multiple machine learning algorithms to identify prognostic LRGs and construct a 6-LRG predictive model.
- Validation using survival analysis, time-dependent ROC curves, and multivariable modeling.
Main Results:
- The 6-LRG model successfully stratified DLBCL patients into distinct overall survival groups across all datasets.
- The model demonstrated robust predictive performance with high Area Under Curve (AUC) values at 1, 3, and 5 years.
- The 6-LRG model proved independent of established clinical variables and enhanced risk prediction when integrated into a nomogram.
Conclusions:
- The 6-LRG model offers valuable prognostic information for DLBCL, potentially refining risk stratification.
- The model highlights distinct biological and immune characteristics associated with different risk groups, suggesting underlying mechanisms.
- Prospective validation in larger cohorts is recommended for clinical implementation.
Keywords:
diffuse large B‐cell lymphomaimmune environmentliquid–liquid phase separationprognostic biomarkerprognostic model
